Kantar Health Combines Big Data, Oncology Expertise

Kantar Health has launched a new big data platform to help clients spot oncology drug opportunities and understand the competitive landscape. Web-based CancerLandscape lets users review more than 2,000 cancer drugs covering more than 175 tumor types.

The company says the new service 'tracks every oncology medicine in development by company, mechanism of action, tumor type, geography and stage of clinical development'. Data will help to evaluate business development and licensing opportunities, identify novel targets for drug development and compare company pipelines.

Cory Lewis, Ph. D., Manager, Oncology Commercial Development, says the new product 'combines the breadth of Big Data with the depth of our large team of Ph.D.-level oncology experts who have the clinical and commercial expertise to provide actionable insights'. He adds: 'The CancerLandscape platform is easy to navigate, visually impactful and interactive, and it's the one place where clients can quickly view the entire cancer landscape within one data source'.

Web site: www.kantarhealth.com .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.

• Kantar Health
• All news